Healthcare entity
Of the tracked stories, 2 of 2 also mention AstraZeneca, the most common co-covered peer. Source depth averages 3 original sources per story, versus 2 across the same-window beat baseline. Their average consequence score of 9 runs above the beat's 5.6 for that window.
Last mentioned: 4d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 2 of 2 also mention AstraZeneca, the most common co-covered peer. Source depth averages 3 original sources per story, versus 2 across the same-window beat baseline. Their average consequence score of 9 runs above the beat's 5.6 for that window. The clearest coverage concentration is acquisition: 1 of 2 stories, with the rest divided among 1 other category. Financial Times appears in 2 tracked Healthcare stories published from August 2, 2026 through August 3, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Financial Times. Shared-story counts are live from our verified record — not editorial picks.
The potential combination of two pharmaceutical powerhouses would concentrate ownership of critical cardiovascular and oncology treatments, raising concerns about pricing power, NHS supply chains, and worldwide health equity.
A potential $400 billion merger between AstraZeneca and Bristol Myers Squibb could reshape oncology competition, with implications for drug costs, patient access, and payer negotiations. The combined portfolio would dominate key cancer markets.
Financial Times is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
